Difficulty: Medium
Average Score: 92%
Practice
Erythropoietin is used commonly to treat the anemia associated with chronic renal failure (CRF). Which condition limits its effectiveness?
Correct answer
B
Rationale
In the context of treating anemia associated with chronic renal failure (CRF) using erythropoietin, the correct answer is B) Depletion of iron stores. Iron is essential for the production of red blood cells, and when patients with CRF are treated with erythropoietin, it stimulates the production of red blood cells, increasing the demand for iron. If the patient's iron stores are depleted, the effectiveness of erythropoietin in correcting anemia will be limited, as there won't be enough iron available for the increased red blood cell production.
Option A) Patient's allergy to erythropoietin is incorrect because an allergy would be a contraindication to using erythropoietin but would not limit its effectiveness in patients who can tolerate it.
Option C) 30% of patients do not respond is incorrect because it reflects a general statistic about patient response rates and does not directly limit the effectiveness of erythropoietin due to iron depletion.
Option D) Anemia is not due to erythropoietin deficiency is incorrect as erythropoietin is used precisely because there is a deficiency in the body's natural production of erythropoietin in CRF, leading to anemia.
Understanding the role of iron in erythropoiesis and the impact of iron stores on the effectiveness of erythropoietin therapy is crucial for healthcare professionals managing patients with CRF and anemia. Monitoring and addressing iron levels are essential components of optimizing the treatment outcomes in these patients.
Option A) Patient's allergy to erythropoietin is incorrect because an allergy would be a contraindication to using erythropoietin but would not limit its effectiveness in patients who can tolerate it.
Option C) 30% of patients do not respond is incorrect because it reflects a general statistic about patient response rates and does not directly limit the effectiveness of erythropoietin due to iron depletion.
Option D) Anemia is not due to erythropoietin deficiency is incorrect as erythropoietin is used precisely because there is a deficiency in the body's natural production of erythropoietin in CRF, leading to anemia.
Understanding the role of iron in erythropoiesis and the impact of iron stores on the effectiveness of erythropoietin therapy is crucial for healthcare professionals managing patients with CRF and anemia. Monitoring and addressing iron levels are essential components of optimizing the treatment outcomes in these patients.